Literature DB >> 23080194

TBK1 suppression of IgA in the NIK of time.

Richard J Bram.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 23080194     DOI： 10.1038/ni.2451

Source DB:  PubMed          Journal:  Nat Immunol        ISSN： 1529-2908            Impact factor:   25.606


× No keyword cloud information.
  13 in total

Review 1.  Homeland security: IgA immunity at the frontiers of the body.

Authors:  Andrew J Macpherson; Markus B Geuking; Kathy D McCoy
Journal:  Trends Immunol       Date:  2012-03-10       Impact factor: 16.687

Review 2.  Innate signaling networks in mucosal IgA class switching.

Authors:  Alejo Chorny; Irene Puga; Andrea Cerutti
Journal:  Adv Immunol       Date:  2010       Impact factor: 3.543

Review 3.  Emerging roles for the non-canonical IKKs in cancer.

Authors:  R R Shen; W C Hahn
Journal:  Oncogene       Date:  2010-11-01       Impact factor: 9.867

4.  Protective antiviral antibody responses in a mouse model of influenza virus infection require TACI.

Authors:  Amaya I Wolf; Krystyna Mozdzanowska; William J Quinn; Michele Metzgar; Katie L Williams; Andrew J Caton; Eric Meffre; Richard J Bram; Loren D Erickson; David Allman; Michael P Cancro; Jan Erikson
Journal:  J Clin Invest       Date:  2011-09-01       Impact factor: 14.808

5.  Allosteric regulation of the ubiquitin:NIK and ubiquitin:TRAF3 E3 ligases by the lymphotoxin-beta receptor.

Authors:  Hideki Sanjo; Dirk M Zajonc; Rebecca Braden; Paula S Norris; Carl F Ware
Journal:  J Biol Chem       Date:  2010-03-26       Impact factor: 5.157

Review 6.  Regulation and function of IKK and IKK-related kinases.

Authors:  Hans Häcker; Michael Karin
Journal:  Sci STKE       Date:  2006-10-17

Review 7.  Selective IgA deficiency in autoimmune diseases.

Authors:  Ning Wang; Nan Shen; Timothy J Vyse; Vidya Anand; Iva Gunnarson; Gunnar Sturfelt; Solbritt Rantapää-Dahlqvist; Kerstin Elvin; Lennart Truedsson; Bengt A Andersson; Charlotte Dahle; Eva Ortqvist; Peter K Gregersen; Timothy W Behrens; Lennart Hammarström
Journal:  Mol Med       Date:  2011-08-04       Impact factor: 6.354

8.  Mice lacking Tbk1 activity exhibit immune cell infiltrates in multiple tissues and increased susceptibility to LPS-induced lethality.

Authors:  Erica Marchlik; Paresh Thakker; Thaddeus Carlson; Zhaozhao Jiang; Mark Ryan; Suzana Marusic; Nadege Goutagny; Wen Kuang; G Roger Askew; Victoria Roberts; Stephen Benoit; Tianhui Zhou; Vincent Ling; Richard Pfeifer; Nancy Stedman; Katherine A Fitzgerald; Lih-Ling Lin; J Perry Hall
Journal:  J Leukoc Biol       Date:  2010-07-22       Impact factor: 4.962

9.  TBK-1 promotes autophagy-mediated antimicrobial defense by controlling autophagosome maturation.

Authors:  Manohar Pilli; John Arko-Mensah; Marisa Ponpuak; Esteban Roberts; Sharon Master; Michael A Mandell; Nicolas Dupont; Wojciech Ornatowski; Shanya Jiang; Steven B Bradfute; Jack-Ansgar Bruun; Tom Egil Hansen; Terje Johansen; Vojo Deretic
Journal:  Immunity       Date:  2012-08-24       Impact factor: 31.745

10.  Heterozygous TBK1 mutations impair TLR3 immunity and underlie herpes simplex encephalitis of childhood.

Authors:  Melina Herman; Michael Ciancanelli; Yi-Hung Ou; Lazaro Lorenzo; Maja Klaudel-Dreszler; Elodie Pauwels; Vanessa Sancho-Shimizu; Rebeca Pérez de Diego; Avinash Abhyankar; Elisabeth Israelsson; Yiqi Guo; Annabelle Cardon; Flore Rozenberg; Pierre Lebon; Marc Tardieu; Edyta Heropolitanska-Pliszka; Damien Chaussabel; Michael A White; Laurent Abel; Shen-Ying Zhang; Jean-Laurent Casanova
Journal:  J Exp Med       Date:  2012-07-30       Impact factor: 14.307
View more
  7 in total

Review 1.  Novel T Follicular Helper-like T-Cell Lymphoma Therapies: From Preclinical Evaluation to Clinical Reality.

Authors:  Adrien Krug; Gamze Tari; Aymen Saidane; Philippe Gaulard; Jean-Ehrland Ricci; François Lemonnier; Els Verhoeyen
Journal:  Cancers (Basel)       Date:  2022-05-12       Impact factor: 6.575

Review 2.  Emerging Roles for Noncanonical NF-κB Signaling in the Modulation of Inflammatory Bowel Disease Pathobiology.

Authors:  Dylan K McDaniel; Kristin Eden; Veronica M Ringel; Irving C Allen
Journal:  Inflamm Bowel Dis       Date:  2016-09       Impact factor: 5.325

Review 3.  NFκB and Kidney Injury.

Authors:  Ning Song; Friedrich Thaiss; Linlin Guo
Journal:  Front Immunol       Date:  2019-04-16       Impact factor: 7.561

Review 4.  Targeting NF-κB-Inducing Kinase (NIK) in Immunity, Inflammation, and Cancer.

Authors:  Kathryn M Pflug; Raquel Sitcheran
Journal:  Int J Mol Sci       Date:  2020-11-11       Impact factor: 5.923

Review 5.  NF-κB signaling in inflammation and cancer.

Authors:  Tao Zhang; Chao Ma; Zhiqiang Zhang; Huiyuan Zhang; Hongbo Hu
Journal:  MedComm (2020)       Date:  2021-12-16

Review 6.  The Therapeutic Potential of Targeting NIK in B Cell Malignancies.

Authors:  Marco V Haselager; Eric Eldering
Journal:  Front Immunol       Date:  2022-07-12       Impact factor: 8.786

Review 7.  Targeting NF-κB pathway for the therapy of diseases: mechanism and clinical study.

Authors:  Hui Yu; Liangbin Lin; Zhiqiang Zhang; Huiyuan Zhang; Hongbo Hu
Journal:  Signal Transduct Target Ther       Date:  2020-09-21
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.